We have located links that may give you full text access.
Allograft Use in Arthroscopic Labral Reconstruction of the Hip With Front-to-Back Fixation Technique: Minimum 2-Year Follow-up.
Arthroscopy 2016 January
PURPOSE: To present minimum 2-year outcomes in patients who underwent a modified technique for arthroscopic labral reconstruction using iliotibial band allograft tissue and a front-to-back fixation.
METHODS: From April 2011 to July 2012, all consecutive arthroscopic labral reconstruction patients were included in this Institutional Review Board-approved, prospective case series study. Inclusion criteria were arthroscopic iliotibial band allograft labral reconstruction performed by a single surgeon, age ≥16 years at the time of arthroscopy, and a minimum of 2 years of follow-up. Patients completed subjective questionnaires both preoperatively and postoperatively, including Modified Harris Hip Score (MHHS), the Lower Extremity Function Score (LEFS), Visual Analogue Scale (VAS) pain scores, and patient satisfaction. A modified front-to-back fixation technique for labral reconstruction was used.
RESULTS: One hundred fifty-two hips (142 patients) met the inclusion criteria for this study; 131 hips (86.2%) had complete follow-up at a minimum of 2 years, and 21 hips (13.8%) were lost to follow-up or had incomplete data during the study period. Seventy hips had concomitant procedures performed; 27 microfracture, 30 chondroplasty, 26 psoas release, 5 os acetabuli resection, and 3 Ganz osteotomy. Overall, 18 hips (13.7%) required revision procedures at a mean of 17 months (range, 1 to 37 months) after the labral reconstruction. In the remaining 113 hips, there was significant improvement in all outcome measures from preoperative to most recent follow-up (P < .0001). The mean MHHS improved by 34 points (P < .0001), and the mean LEFS improved by 27 points (P < .0001). The mean VAS pain score improved by 3 points at rest (P < .0001), 4 points with average pain with daily activities (P < .0001), and 5 points with sport (P < .0001). Patients reported an overall satisfaction of 9 (range, 1 to 10).
CONCLUSIONS: Arthroscopic iliotibial band allograft labral reconstruction of the hip shows promising outcomes at minimum 2-year follow-up.
LEVEL OF EVIDENCE: Level IV, therapeutic case series.
METHODS: From April 2011 to July 2012, all consecutive arthroscopic labral reconstruction patients were included in this Institutional Review Board-approved, prospective case series study. Inclusion criteria were arthroscopic iliotibial band allograft labral reconstruction performed by a single surgeon, age ≥16 years at the time of arthroscopy, and a minimum of 2 years of follow-up. Patients completed subjective questionnaires both preoperatively and postoperatively, including Modified Harris Hip Score (MHHS), the Lower Extremity Function Score (LEFS), Visual Analogue Scale (VAS) pain scores, and patient satisfaction. A modified front-to-back fixation technique for labral reconstruction was used.
RESULTS: One hundred fifty-two hips (142 patients) met the inclusion criteria for this study; 131 hips (86.2%) had complete follow-up at a minimum of 2 years, and 21 hips (13.8%) were lost to follow-up or had incomplete data during the study period. Seventy hips had concomitant procedures performed; 27 microfracture, 30 chondroplasty, 26 psoas release, 5 os acetabuli resection, and 3 Ganz osteotomy. Overall, 18 hips (13.7%) required revision procedures at a mean of 17 months (range, 1 to 37 months) after the labral reconstruction. In the remaining 113 hips, there was significant improvement in all outcome measures from preoperative to most recent follow-up (P < .0001). The mean MHHS improved by 34 points (P < .0001), and the mean LEFS improved by 27 points (P < .0001). The mean VAS pain score improved by 3 points at rest (P < .0001), 4 points with average pain with daily activities (P < .0001), and 5 points with sport (P < .0001). Patients reported an overall satisfaction of 9 (range, 1 to 10).
CONCLUSIONS: Arthroscopic iliotibial band allograft labral reconstruction of the hip shows promising outcomes at minimum 2-year follow-up.
LEVEL OF EVIDENCE: Level IV, therapeutic case series.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices 
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app